KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Ionis Pharmaceuticals (IONS) over the last 16 years, with Dec 2024 value amounting to $217.9 million.

  • Ionis Pharmaceuticals' Prepaid Assets rose 32.33% to $243.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.7 million, marking a year-over-year increase of 32.33%. This contributed to the annual value of $217.9 million for FY2024, which is 6.09% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Prepaid Assets of $217.9 million as of FY2024, which was up 6.09% from $205.4 million recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Prepaid Assets registered a high of $217.9 million during FY2024, and its lowest value of $140.2 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $205.4 million (2023), whereas its average is $197.2 million.
  • Data for Ionis Pharmaceuticals' Prepaid Assets shows a peak YoY climbed of 22.10% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Ionis Pharmaceuticals' Prepaid Assets stood at $140.2 million in 2020, then grew by 2.29% to $143.4 million in 2021, then increased by 17.35% to $168.3 million in 2022, then increased by 22.10% to $205.4 million in 2023, then grew by 6.09% to $217.9 million in 2024.